Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society of Hematology (ASH) Annual Meeting about maintenance therapy with rituximab for the management of patients with mantle cell lymphoma.
This programme has been supported by sponsorship from Celgene.
